Flisser A, García-Malo F, Canepa MA, Doncel S, Espinoza R, Moreno R, Avila I, Pérez-Palacios G, Tapia-Conyer R, Fuente JR

Language: English
References: 17
Page: 431-436
PDF size: 45.64 Kb.

ABSTRACT

Objective. To evaluate cytology laboratories and the performance of cytotechnologists for establishing efficient external quality control for Mexico’s National Program for the Prevention and Control of Cervical Cancer. Material and Methods. During January and February 1998, an onsite evaluation of all cytology laboratories of the Ministry of Health found that only 70% of the microscopes were in adequate working conditions, reagents were out of date,and working conditions were sub-optimal. A program for external quality control based on proficiency testing was established for cytotechnologists. Fifty slide sets with 20 Papanicolaou slides and 10 photographic slides were prepared. The sets were given to the cytotechnologists for evaluation and again one year later by courier. Results. Twenty-one percent of microscopes were repaired and 9% replaced; reagents were distributed and laboratory facilities improved. Only 16% of cytotechnologists passed the initial proficiency test. Cytotechnologists received a refresher training course: one year later 67% of them passed the proficiency test. To ascertain that each slide was correctly diag nosed, 41 sets were rescreened by expert cytopathologists or cytologists and their diagnoses compared to the original ones. Thirty-seven sets had 86% to 96% concordance. Conclusions. This new system for external quality control of cervical cytology allowed the opportune and reliable evaluation of the performance of cytotechnologists.

REFERENCES

1. Robles S. Introduction to the special issue: Timely detection of cervical cancer. Bull PAHO 1996:30:285-289.

2. Laara E, Day E, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organized screening programs. Lancet 1987;1:1279-1281.

3. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 1941;42:193.

4. Johannesson G, Geirsson G, Day NE. The effect of mass screening in Iceland. 1965-1974, on the incidence and mortality of cervical carcinoma. Intl J Cancer 1978;21:418.

5. Boyes DA, Nichols TM, Millner AM, Worth AJ. Recent results from the British Columbia screening program for cervical caner. Am J Obstet Gynecol 1977;128:692.

6. Restrepo HE, González JL, Roberts E, Litvak J. Epidemiología y control del cáncer del cuello uterino en América Latina y El Caribe. Bol Oficina Sanit Panam 1987;102:578.

7. García G. La detección de cáncer del cuello uterino en 75 855 mujeres. Gac Med Mex 1970;100:154.

8. Weissbrod-de Bonder D, Magis-Rodríguez C. Control de calidad del diagnóstico citológico de displasias en México. Higiene 1994;II: 207-212.

9. Weissbrod D, Torres M, Rodríguez A, Ureña I, Estrada J, Reyes ML et al. Comparación del examen de citología cervical efectuado por el método Papnet y por microscopía convencional. Bol Oficina Sanit Panam 1996;121:528-535.

10. Secretaría de Salud. Norma Oficial Mexicana. NOM-014-SSA2-1994, para la Prevención, Detección, Diagnóstico, Tratamiento, Control y Vigilancia Epidemiológica del Cáncer Cérvico Uterino. México, D.F.: Diario Oficial, Marzo 6, 1998.

11. Organización Panamericana de la Salud. Manual de normas y procedimientos para el control del cáncer de cuello uterino. PALTEX 1990;6;37-43.

12. Lazcano-Ponce EC, Buiatti E, Nájera-Aguilar P, Alonso-de Ruiz P, Hernández- Avila M. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Cancer Causes Control 1998;9:241-251.

13. Lazcano-Ponce EC, Alonso-de Ruiz P, López-Carrillo L, Nájera-Aguilar P, Avila-Cisneros R, Escandón-Romero C et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centres in Mexico. Acta Cytol 1997;41:277-284.

14. Alonso-de Ruiz P, Lazcano-Ponce EC. Quality control in cytopathology laboratories in six Latin American countries. In: Compendium on quality assurance, proficiency testing and workload limitations in clinical cytology. 1995:115-121.

15. United States Department of Health and Human Services. Health care financing administration. Medicare, Medicaid and CLIA Programs. Regulations implementing the clinical laboratory improvement amendments of 1988 (CLIA). Federal Register 1992;57(49):7002-7186.

16. Organización Panamericana de la Salud. Módulo de Citología. Procedimientos. Washington, D.C., 2000:1-20.

17. Alonso-de Ruiz P, Lazcano-Ponce EC, Hernández-Avila M. Cáncer cervicouterino. Diagnóstico, prevención y control. México, D.F.: Editorial Médica Panamericana, 2000: 203-209.